Clinical Trials List
2024-10-15 - 2029-10-31
Phase III
Recruiting3
ICD-10K74.4
Secondary biliary cirrhosis
ICD-10K75.81
Nonalcoholic steatohepatitis (NASH)
ICD-10K76.0
Fatty (change of) liver, not elsewhere classified
ICD-10K76.89
Other specified diseases of liver
ICD-10R16.2
Hepatomegaly with splenomegaly, not elsewhere classified
ICD-9571.8
Other chronic nonalcoholic liver disease
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 許銘澤 Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 曾岱宗 Division of General Internal Medicine
- PEI-JER CHEN Division of General Internal Medicine
- 蘇東弘 Division of General Internal Medicine
- 楊宏志 Division of General Internal Medicine
- Jia-Horng Kao Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jee-Fu Huang Digestive System Department
- Wan-Long Chuang Digestive System Department
- Chia-Yen Dai Digestive System Department
- 林宜竑 Digestive System Department
- Chung-Feng Huang Digestive System Department
- 梁博程 Digestive System Department
- Ming-Lun Yeh Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
1050 participants
